This indicates that TNFAIP3 SNP analysis before TNF-blocking therapy initiation is worthwhile to perform in several autoimmune diseases and may be more practical than evaluating TNFAIP3 mRNA expression. The gene discussed is TNFAIP3; the disease is autoimmune disease.